SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ECHENBERG PAUL S

(Last)

(First)

(Middle)

623 SYDENHAM AVE

(Street)

WESTMONT QUEBEC CANADA

H3Y 2Z3

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/26/2004

3. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock options (right to buy)	⁽¹⁾	03/04/2007	Common stock	78,409	$4.35	D
Common stock options (right to buy)	⁽¹⁾	05/30/2008	Common stock	2,091	$4.35	D
Common stock options (right to buy)	⁽¹⁾	05/29/2009	Common stock	2,091	$4.35	D
Common stock options (right to buy)	⁽²⁾	06/03/2010	Common stock	2,091	$4.35	D
Common stock options (right to buy)	⁽³⁾	06/02/2011	Common stock	2,091	$4.35	D
Common stock options (right to buy)	⁽⁴⁾	05/21/2012	Common stock	2,091	$6.52	D
Common stock options (right to buy)	⁽⁵⁾	05/31/2013	Common stock	6,273	$6.52	D

Explanation of Responses:

1. Exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders.

2. Options for 80% of the shares will become exercisable on the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 20% of the shares will become exercisable on the later of 6/3/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided, that if such distribution does not occur before 6/3/2005, then such options will become exercisable on 8/2/2005.

3. Options for 60% of the shares will become exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 20% of the shares will become exercisable upon the later of 6/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided, that if such distribution does not occur before 6/2/2005, then such options will become exercisable on 8/2/2005. Options for 20% of the shares will become exercisable on 6/2/2006.

4. Options for 40% of the shares will become exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 20% of the shares will become exercisable upon the later of 5/21/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided, that if such distribution does not occur by 5/21/2005, then such options will become exercisable on 8/2/2005. Options for 20% of the shares are each exercisable on 5/21/2006 and 5/21/2007, respectively.

5. Options for 20% of the shares will become exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. commmon stock to its stockholders. Options for 20% of the shares will become exercisable on the later of 5/31/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided, that if such distribution does not occur before 5/3/2005, then such options will become exercisable on 8/2/2005. Options for 20% of the shares are each exercisable on 5/31/2006, 5/31/2007, and 5/31/2008, respectively.

	Ronald F. Lamy as attorney in fact for Paul Echenberg	05/26/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.